Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Conjunctival Mucosa-Associated Lymphoid Tissue Lymphoma”

3 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 3 of 3 results

Testing effectiveness (Phase 2)Study completedNCT01427114
What this trial is testing

R-CVP for the Treatment of Non-conjunctival Ocular Adnexal MALT Lymphoma (OAML)

Who this might be right for
Lymphoma
Konkuk University Medical Center 33
Testing effectiveness (Phase 2)Study completedNCT01514344
What this trial is testing

Intralesional Rituximab for the Treatment of Conjunctival Indolent Lymphoma

Who this might be right for
Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma
Andres J. M. Ferreri 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07583810
What this trial is testing

Non-covalent BTK Inhibitor Nemtabrutinib in Combination With the CD20 Monoclonal Antibody Rituximab for the Treatment of Marginal Zone Lymphoma

Who this might be right for
Conjunctival Mucosa-Associated Lymphoid Tissue LymphomaGastric Mucosa-Associated Lymphoid Tissue LymphomaMarginal Zone Lymphoma+4 more
City of Hope Medical Center 35